A genetically engineered Plasmodium falciparum parasite vaccine provides protection from controlled human malaria infection
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A genetically engineered
Plasmodium falciparum
parasite vaccine provides protection from controlled human malaria infection
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 14, Issue 659, Pages -
Publisher
American Association for the Advancement of Science (AAAS)
Online
2022-08-25
DOI
10.1126/scitranslmed.abn9709
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial
- (2021) Mehreen S Datoo et al. LANCET
- Two chemoattenuated PfSPZ malaria vaccines induce sterile hepatic immunity
- (2021) Agnes Mwakingwe-Omari et al. NATURE
- Safety, infectivity and immunogenicity of a genetically attenuated blood-stage malaria vaccine
- (2021) Rebecca Webster et al. BMC Medicine
- Safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trial
- (2021) Mahamadou S Sissoko et al. LANCET INFECTIOUS DISEASES
- IMRAS—A clinical trial of mosquito-bite immunization with live, radiation-attenuated P. falciparum sporozoites: Impact of immunization parameters on protective efficacy and generation of a repository of immunologic reagents
- (2020) Bradley Hickey et al. PLoS One
- A replication-competent late liver stage–attenuated human malaria parasite
- (2020) Debashree Goswami et al. JCI Insight
- Multidose Priming and Delayed Boosting Improve PfSPZ Vaccine Efficacy against Heterologous P. falciparum Controlled Human Malaria Infection
- (2020) Kirsten E Lyke et al. CLINICAL INFECTIOUS DISEASES
- Safety, tolerability, and immunogenicity of PfSPZ Vaccine administered by direct venous inoculation to infants and young children: findings from an age de-escalation, dose-escalation double-blinded randomized, controlled study in western Kenya
- (2019) Laura C Steinhardt et al. CLINICAL INFECTIOUS DISEASES
- Malaria Vaccines: Recent Advances and New Horizons
- (2018) Simon J. Draper et al. Cell Host & Microbe
- Prime-and-Trap Malaria Vaccination To Generate Protective CD8+Liver-Resident Memory T Cells
- (2018) Tayla M. Olsen et al. JOURNAL OF IMMUNOLOGY
- Prime and target immunization protects against liver-stage malaria in mice
- (2018) Anita Gola et al. Science Translational Medicine
- Antibody-Mediated Protection against Plasmodium Sporozoites Begins at the Dermal Inoculation Site
- (2018) Yevel Flores-Garcia et al. mBio
- Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trial
- (2017) Mahamadou S Sissoko et al. LANCET INFECTIOUS DISEASES
- Complete attenuation of genetically engineeredPlasmodium falciparumsporozoites in human subjects
- (2017) James G. Kublin et al. Science Translational Medicine
- Liver-Resident Memory CD8 + T Cells Form a Front-Line Defense against Malaria Liver-Stage Infection
- (2016) Daniel Fernandez-Ruiz et al. IMMUNITY
- Mosquito bite immunization with radiation-attenuated Plasmodium falciparum sporozoites: safety, tolerability, protective efficacy and humoral immunogenicity
- (2016) Bradley W. Hickey et al. MALARIA JOURNAL
- Protection against malaria at 1 year and immune correlates following PfSPZ vaccination
- (2016) Andrew S Ishizuka et al. NATURE MEDICINE
- Novel approaches to whole sporozoite vaccination against malaria
- (2015) Else M. Bijker et al. VACCINE
- Evaluation of the Efficacy of ChAd63-MVA Vectored Vaccines Expressing Circumsporozoite Protein and ME-TRAP Against Controlled Human Malaria Infection in Malaria-Naive Individuals
- (2014) Susanne H. Hodgson et al. JOURNAL OF INFECTIOUS DISEASES
- A Next-generation Genetically Attenuated Plasmodium falciparum Parasite Created by Triple Gene Deletion
- (2014) Sebastian A Mikolajczak et al. MOLECULAR THERAPY
- Safety and Comparability of Controlled Human Plasmodium falciparum Infection by Mosquito Bite in Malaria-Naïve Subjects at a New Facility for Sporozoite Challenge
- (2014) Angela K. Talley et al. PLoS One
- Immunization with genetically attenuated P. falciparum parasites induces long-lived antibodies that efficiently block hepatocyte invasion by sporozoites
- (2014) Olivia C. Finney et al. VACCINE
- Four-Year Efficacy of RTS,S/AS01E and Its Interaction with Malaria Exposure
- (2013) Ally Olotu et al. NEW ENGLAND JOURNAL OF MEDICINE
- A T-cell response to a liver-stage Plasmodium antigen is not boosted by repeated sporozoite immunizations
- (2013) S. C. Murphy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine
- (2013) R. A. Seder et al. SCIENCE
- Genetic engineering of attenuated malaria parasites for vaccination
- (2012) Shahid M Khan et al. CURRENT OPINION IN BIOTECHNOLOGY
- Laser Cutting Eliminates Nucleic Acid Cross-Contamination in Dried-Blood-Spot Processing
- (2012) S. C. Murphy et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Development of a quantitative flow cytometry-based assay to assess infection by Plasmodium falciparum sporozoites
- (2012) Alexis Kaushansky et al. MOLECULAR AND BIOCHEMICAL PARASITOLOGY
- A Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Infants
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Whole parasite vaccination approaches for prevention of malaria infection
- (2012) Noah S. Butler et al. TRENDS IN IMMUNOLOGY
- Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study
- (2011) Meta Roestenberg et al. LANCET
- Live Attenuated Malaria Vaccine Designed to Protect Through Hepatic CD8+ T Cell Immunity
- (2011) J. E. Epstein et al. SCIENCE
- Gene deletion from Plasmodium falciparum using FLP and Cre recombinases: Implications for applied site-specific recombination
- (2010) Matthew T. O’Neill et al. INTERNATIONAL JOURNAL FOR PARASITOLOGY
- That Was Then But This Is Now: Malaria Research in the Time of an Eradication Agenda
- (2010) S. H. I. Kappe et al. SCIENCE
- Protection against a Malaria Challenge by Sporozoite Inoculation
- (2009) Meta Roestenberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Kinetics of Mosquito-Injected Plasmodium Sporozoites in Mice: Fewer Sporozoites Are Injected into Sporozoite-Immunized Mice
- (2009) Chahnaz Kebaier et al. PLoS Pathogens
- Type II fatty acid synthesis is essential only for malaria parasite late liver stage development
- (2008) Ashley M. Vaughan et al. CELLULAR MICROBIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now